GlassScriptPhysician profile
David J Prybyla
NPI 1104864495
$11,537.28
in general payments reported to CMS, 2019-2025
9 companies · $2,647 in 2025
The $2,647 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $60.05 · 2021: $598 · 2022: $70.60 · 2023: $7,821 · 2024: $140 · 2025: $2,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,061 · Travel and Lodging: $2,714 · Food and Beverage: $1,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,061.19 |
| Travel and Lodging | $2,713.52 |
| Food and Beverage | $1,833.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $7,292.00 | 2023 | Velys |
| Zimmer Biomet Holdings, INC. | $3,052.28 | 2021-2025 | Oxford, Avenir, G7 |
| Depuy Synthes Sales INC. | $641.90 | 2019-2025 | Attune, Actis |
| Orthalign INC | $250.00 | 2025 | Orthalign Plus |
| Medical Device Business Services, INC. | $197.25 | 2022-2024 | Velys |
| Smith+Nephew, INC. | $64.32 | 2020-2024 | Pico 7 |
| Avanos Medical | $13.71 | 2021 | |
| Ethicon US, LLC | $13.47 | 2023 | Surgicel Nu-Knit |
| Pacira Pharmaceuticals Incorporated | $12.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Prybyla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.